Go to the profile of Epygenix Therapeutics, Inc.

Epygenix Therapeutics, Inc.

 

About Epygenix Therapeutics, Inc.

Epygenix Therapeutics, Inc. is developing precision medicine for rare and catastrophic forms of genetic epilepsy, such as Dravet Syndrome, Lennox-Gastaut Syndrome, Infantile Spasm, and Otahara syndrome.

Therapeutic Areas

Other

Technologies

Drug delivery Small molecules

Company Type

Biotechnology – R&D services

State of Ownership

Private

Sponsorship Group

Networker

Topics

Topics contributed to:

Drug Development

Editions participated in:

June 2017